Abstract
AMY is a member of the calcitonin gene-related peptide (CGRP) family and consists of a single intramolecular ring structure and amidated C-terminus, which are common to the family members. AMY is co-secreted with insulin from pancreatic β cells and is considered to be involved in glucose homeostasis. AMY is normally in a soluble monomeric state, but forms amyloid fibrils and eventually leads to the aggregation of islet amyloid in patients with type 2 diabetes. The human AMY 20–29 region is responsible for fibril formation, and synthesized AMY based on the rat sequence with the variation in the region is used for treatment of type 1 and type 2 diabetes. AMY KO mice show increased insulin responses, high systolic blood pressure, and reduced nociceptive hypersensitivity.
Original language | English |
---|---|
Title of host publication | Handbook of Hormones |
Subtitle of host publication | Comparative Endocrinology for Basic and Clinical Research |
Publisher | Elsevier |
Pages | 245,e27F-1-246,e27F-3 |
ISBN (Electronic) | 9780128010280 |
ISBN (Print) | 9780128010679 |
DOIs | |
Publication status | Published - Jan 1 2015 |
Keywords
- glucose homeostasis
- insulin
- islet amyloid
- pancreas
- type 2 diabetes
ASJC Scopus subject areas
- Medicine(all)